USPTO serial 86176866
EGJ IMLAB
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- BHANOT, KAPIL KUMAR
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with EGJ IMLAB?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
George G. Wang
GEORGE G. WANG BEI & OCEAN66 HILLTOP RDMILLINGTON, NJ 07946-1416UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | 3-in-1 hair conditioners; 3-in-1 hair shampoos; 3-in-1 organic soap bars for use as soap, shampoo and conditioner; Anti-bacterial soap; Antibacterial soap; Antiperspirant soap; Baby hair conditioner; Baby hand soap; Baby lotion; Baby shampoo; Bar soap; Bath gel; Bath gels; Bath lotion; Bath soaps; Bath soaps in liquid, solid or gel form; Bathing lotions; Bleaching preparations for cosmetic purposes; Bleaching preparations for household use; Bleaching preparations for laundry use; Bleaching preparations for the hair; Cleaning agents and preparations; Cleaning and polishing preparations; Cleaning and washing preparations; Cleaning preparations; Cleaning preparations for cleaning surfaces; Cleaning preparations for cleansing drains; Cleaning preparations for household purposes; Cleaning preparations for medical ventilator equipment, tubing, masks; Cleaning preparations for hands, automobiles, ovens; Cleaning preparations that eliminate bacteria that cause products to age or produce foul odors; Cleaning, washing and polishing preparations; Cleansing milk; Conditioners; Dental bleaching gel; Dental bleaching gels; Denture cleaners; Denture cleaning preparations; Denture polishes; Detergent soap; Detergents for household use; Fabric softeners; Fabric softeners for laundry use; Hair conditioner; Hair conditioners; Hair conditioners for babies; Hair shampoo; Hair shampoos and conditioners; Laundry detergent; Laundry detergents; Laundry fabric conditioner; Laundry soap; Medicated soap; Mouth washes; Mouthwash; Mouthwashes; Non-medicated dental rinse; Non-medicated mouth rinse; Non-medicated mouth wash and rinse; Non-medicated mouth washes; Non-medicated mouthwash and gargle; Non-medicated mouthwashes; Scouring liquids; Shampoo-conditioners; Shampoos; Shampoos for babies; Shampoos for pets; Shower gel; Shower gels; Skin cleansers; Skin cleansing cream; Skin cleansing lotion; Soaps; Soaps and detergents; Soaps for babies; Soaps for body care; Soaps for household use; Soaps for personal use; Soaps for toilet purposes; Teeth cleaning lotions; Toilet soap; Toilet soaps; Tooth cleaning preparations; Tooth gel; Tooth paste; Tooth paste in soft cake; Tooth whitening gels; Tooth whitening pastes; Tooth whitening preparations; Toothpaste; Toothpaste and mouthwashes; Toothpastes; Washing powder; Washing preparations and laundry bleach; Washing-up liquids | ACTIVE | — |
| 005 | Anti-inflammatory ointments; Anti-itch ointment; Antibiotic ointments; Baby food; Baby foods; Biocides, germicides, bactericides, virucides, fungicides, insecticides, pesticides and herbicides; Biological fungicides; Biological herbicides; Biological implants, namely, a vital processed human or animal connective tissue; Biological indicators for monitoring sterilization processes for medical or veterinary purposes; Biological preparations for the treatment of cancer; Biological tissue cultures for medical purposes; Biological tissue cultures for veterinary purposes; Biological tissue grafts; Biological bone, skin tissue intended for subsequent implantation; Capsules sold empty for pharmaceuticals; Chemical preparations for pharmaceutical or medical purposes, namely, for improving general health; Chemical preparations for sanitary purposes; Chemical preparations for sanitary use; Chemical preparations for treating mildew; Chemical preparations for treating phylloxera; Chemical preparations to treat mildew; Chemical preparations to treat wheat smut; Chemical reagents for medical or veterinary purposes; Diet capsules; Diet pills; Dietary fiber for treating constipation; Dietary fiber to aid digestion; Dietary food supplements; Dietary supplemental drinks; Dietary supplemental drinks in the nature of vitamin and mineral beverages; Dietary supplements; Dietary supplements for human consumption; Disinfectant bathroom cleaners; Disinfectant toilet bowl cleaners; Disinfectants for chemical toilets; Disinfectants for contact lenses; Disinfectants for hygiene purposes; Disinfectants for hygienic purposes; Disinfectants for medical instruments; Disinfectants for sanitary purposes; Disinfectants for swimming pools; Disinfecting handwash; Fecal enzyme inhibiting compositions used as an ingredient in medicated creams, ointments and lotions; Food for babies; Food for infants; Food for infants, namely, human breast milk; Gelatin capsules sold empty for pharmaceuticals; Hemorrhoidal ointments; Herb teas for medicinal purposes; Herbal anti-itch and sore skin ointment for pets; Herbal topical creams, gels, salves, sprays, powder, balms, liniment and ointments for the relief of aches and pain; Herbs for medicinal purposes; Liquid protein supplements; Liquid vitamin supplements; Medicated diaper rash ointments and lotions; Medicated ointments for treating dermatological conditions; Medicated skin care preparations; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels; Medicated sunburn ointments; Medicinal herb extracts; Medicinal herbal extracts for medical purposes; Medicinal herbal preparations; Medicinal herbs; Medicinal preparations for stimulating hair growth; Medicinal preparations for the mouth and as sprays; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Medicinal preparations for improving general health; Medicines for dental purposes; Medicines for the treatment of gastrointestinal diseases; Mentholated ointment for medical use; Mercurial ointments for medical use; Nutraceuticals for the treatment of illness; Nutraceuticals for use as a dietary supplement; Nutritional and dietary supplements formed and packaged as bars; Nutritional drinks for animals; Nutritional food additives for medical purposes in the nature of natural food extracts derived from fish, meat, vegetables; Nutritional meal replacement bars adapted for medical use for individuals undergoing medical treatments; Nutritional supplement energy bars; Nutritional supplement for eliminating toxins from the body; Nutritional supplement for eliminating toxins from the intestinal tract; Nutritional supplement in the nature of a nutrient-dense, protein-based drink mix; Nutritional supplement meal replacement bars for boosting energy; Nutritional supplement shakes; Nutritional supplements; Nutritional supplements in capsule form for dogs; Nutritional supplements in lotion form sold as a component of nutritional skin care products; Nutritional supplements in the nature of nutritionally fortified soft chews; Nutritional supplements, namely, carbohydrates in powdered form; Nutritional supplements, namely, probiotic compositions; Nutritionally fortified beverages; Nutritionally fortified water; Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents for epidermis; Pharmaceutical agents for treating physically caused lesions; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for skin care; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for reducing sexual activity; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of worms in pets; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, dantrolene sodium for injection; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for chloasma; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for pregnancy blemishes; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for ophthalmological use; Pharmaceutical products for skin care for animals; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical skin lotions; Pharmaceutical solutions used in dialysis; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, anti-infectives; Pharmaceuticals, namely, antihelmintics; Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, lipid lowering agents; Pharmaceuticals, namely, psychotropics; Pheromones for medical use; Vitamin supplements; Vitamins | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Generex Pharmaceuticals, Inc.
- Other trademarks owned by Generex Pharmaceuticals, Inc.
- Other trademarks in Class 003
- Other trademarks in Class 005
- Similar marks named EGJ IMLAB
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 21, 2016 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 21, 2016 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 1, 2015 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 29, 2015 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Aug 29, 2015 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Aug 17, 2015 | EXT1 | SOU EXTENSION 1 FILED | — |
| Aug 17, 2015 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 17, 2015 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 23, 2014 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 23, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 3, 2014 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 14, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 13, 2014 | ALIE | ASSIGNED TO LIE | — |
| Oct 28, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 28, 2014 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 28, 2014 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 28, 2014 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 28, 2014 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 2, 2014 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| May 2, 2014 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| May 2, 2014 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Apr 30, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 8, 2014 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Feb 7, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 31, 2014 | NWAP | NEW APPLICATION ENTERED | — |